Estrogen-based hormone replacement therapy (HRT) prescribing more than doubled from 2018 to 2026. The largest increases were seen in patches and vaginal creams, with patch use more than tripling and vaginal cream use increasing more than fourfold. The rates of women...
Seizure frequency is one of the most important outcomes in epilepsy research, but it often lives in unstructured clinical notes rather than standard EHR fields. In a recent Neurology abstract, researchers from SK Life Science and Truveta show how the Truveta Language...
Respiratory virus-associated hospitalizations declined slightly in February 2026 to 3.6% of all hospitalizations. Among children aged 0-4 years, respiratory virus-associated hospitalizations increased slightly to 4.3% of all hospitalizations, with the increase driven...
Older adults remain at highest risk for COVID-19–related hospitalization. Yet a new CDC analysis suggests that effective antiviral treatments are likely underprescribed among outpatients aged 65 or older, with prescribing patterns varying alongside disease...
A large proportion of early users (36.1%) of oral semaglutide (Wegovy pill) had no prior evidence of GLP-1-based medication use, suggesting rapid uptake among patients new to taking GLP-1 medications. Among patients who previously used a GLP-1-based medication, most...